| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0005 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0007 |